Karan S Dixit

Employment

• Northwestern University, Evanston, IL

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (100)

• Gyriform Susceptibility Rim in Early Progressive Multifocal Leukoencephalopathy.
  Annals of Neurology 2026 DOI: 10.1002/ana.78368
  +Save
• Teaching NeuroImage: A Case of Suspected Bisphosphonate-Induced Intraorbital Inflammation
  Neurology 2026 DOI: 10.1212/WNL.0000000000218485
  +Save
• Elevated neutrophil-to-lymphocyte ratio as a prognostic factor in primary central nervous system lymphoma.
  Neuro-Oncology Advances 2026 DOI: 10.1093/noajnl/vdag124
  +Save
• Medical therapies for glioneuronal tumors
  2026 DOI: 10.1016/B978-0-443-27356-8.00003-6
  +Save
• A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combination
  Journal of Neuro-Oncology 2026 DOI: 10.1007/s11060-026-05446-1
  +Save
• Assessments of social vulnerability on central nervous system cancer disparities in the United States
  Communications Medicine 2026 DOI: 10.1038/s43856-026-01409-9
  +Save
• Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastoma.
  JCI insight 2026 DOI: 10.1172/jci.insight.198475
  +Save
• Polymorphic central nervous system (CNS) immune deficiency/dysregulation-associated lymphoproliferative disorders show a uniquely aggressive clinicopathologic profile compared to their extra-CNS counterparts.
  Human Pathology 2026 DOI: 10.1016/j.humpath.2026.106051
  +Save
• First report of a clinical and radiologic response to vorasidenib in a patient with isocitrate dehydrogenase-mutant brainstem astrocytoma.
  Neuro-Oncology Practice 2026 DOI: 10.1093/nop/npaf131
  +Save
• Efficacy of tepotinib in patients with high-grade glioma with MET alterations: A case series
  Neuro-Oncology Practice 2026 DOI: 10.1093/nop/npaf130
  +Save